ASIA SEED Co.,Ltd. (KOSDAQ:154030)

Sage Therapeutics Revenue

ASIA SEED had revenue of 9.19B KRW in the quarter ending March 31, 2025, with 15.20% growth. This brings the company's revenue in the last twelve months to 26.79B, up 7.82% year-over-year. In the fiscal year ending September 30, 2024, ASIA SEED had annual revenue of 24.59B, down -6.83%.

• Revenue (ttm): 26.79B
• Revenue Growth: +7.82%
• P/S Ratio: 1.04
• Revenue / Employee: 144.81M
• Employees: 185
• Market Cap: 27.74B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	24.59B	-1.80B	-6.83%
Sep 30, 2023	26.40B	2.35B	9.77%
Sep 30, 2022	24.05B	-330.72M	-1.36%
Sep 30, 2021	24.38B	1.53B	6.72%
Sep 30, 2020	22.84B	4.77B	26.37%